SEC 13F Intelligence

Acadian Asset Management LLC / ABT

Acadian Asset Management LLC’s Abbott Laboratories Position

Does Acadian Asset Management LLC own Abbott Laboratories (ABT)? Yes — 3.22M shares worth $331M (+0.47% of its 13F portfolio) as of Q1 2026, down from 4.68M shares the prior filed quarter.

Position Value
$331M
Q1 2026
Shares
3.22M
% of Portfolio
+0.47%
Quarters Held
27
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $10MQ3 ’19: $3MQ2 ’20: $7MQ3 ’20: $9MQ3 ’20Q4 ’20: $14MQ1 ’21: $63MQ2 ’21: $58MQ3 ’21: $33MQ3 ’21Q4 ’21: $50MQ1 ’22: $52MQ2 ’22: $41MQ3 ’22: $13MQ3 ’22Q4 ’22: $10MQ1 ’23: $8MQ2 ’23: $4MQ3 ’23: $2MQ3 ’23Q4 ’23: $4MQ1 ’24: $6MQ2 ’24: $33MQ3 ’24: $86MQ3 ’24Q4 ’24: $119MQ1 ’25: $211MQ2 ’25: $394MQ3 ’25: $517MQ3 ’25Q4 ’25: $587MQ1 ’26: $331Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.22M$331M+0.47%
Q4 20254.68M$587M+0.96%
Q3 20253.86M$517M+0.90%
Q2 20252.90M$394M+0.81%
Q1 20251.59M$211M+0.59%
Q4 20241.05M$119M+0.34%
Q3 2024756.2K$86M+0.27%
Q2 2024319.2K$33M+0.10%
Q1 202452.3K$6M+0.02%
Q4 202336.0K$4M+0.02%
Q3 202325.8K$2M+0.01%
Q2 202336.0K$4M+0.02%
Q1 202382.9K$8M+0.04%
Q4 202293.2K$10M+0.05%
Q3 2022133.4K$13M+0.07%
Q2 2022374.4K$41M+0.21%
Q1 2022436.0K$52M+0.21%
Q4 2021356.7K$50M+0.19%
Q3 2021276.4K$33M+0.12%
Q2 2021501.4K$58M+0.22%
Q1 2021529.2K$63M+0.25%
Q4 2020126.5K$14M+0.05%
Q3 202085.2K$9M+0.04%
Q2 202079.8K$7M+0.03%
Q3 201935.1K$3M+0.01%
Q1 2019126.0K$10M+0.04%
Q4 2018176.3K$13M+0.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of ABT.